Elizabeth Grace Hand, founder of Ställe Studios and New York's most sought-after facialist, dismisses tretinoin as overrated in her latest interview for Fashionista's "Face It" video series. The esthetician champions exosomes instead, positioning the cellular-derived treatment as the superior alternative for skin transformation.
Hand's contrarian stance challenges the dermatological establishment's decades-long reliance on retinoid prescriptions. While tretinoin remains the gold standard for anti-aging and acne-prone skin, exosomes represent a newer frontier in aesthetic medicine. These microscopic extracellular vesicles deliver proteins and growth factors directly to skin cells, theoretically bypassing the irritation and adjustment periods tretinoin demands.
Her skepticism extends beyond ingredient hierarchies. Hand identifies specific skin-care trends she views as complete scams, though the interview withholds her full list. This transparency aligns with her brand positioning. Ställe Studios markets itself as a no-nonsense skincare destination for New York's discerning clientele.
The facialist also reveals that the cheapest component of her personal routine contradicts luxury positioning. This detail grounds her advice in accessibility rather than exclusivity, a refreshing pivot from typical aesthetician rhetoric.
Hand's emerging influence in celebrity and wellness circles reflects broader market shifts. Exosome treatments have gained traction among high-net-worth individuals willing to pay premium prices for cutting-edge cellular science. Her endorsement accelerates mainstream conversation around post-tretinoin alternatives, particularly for patients experiencing retinoid sensitivity or seeking novel protocols.
The "IYKYK" label signals Hand's insider status among Manhattan's beauty cognoscenti. Her contrarian takes on established treatments resonate with an audience fatigued by influencer skincare orthodoxy. Whether exosomes deliver transformative results or function